You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page

No matches

Pulmonology

ADVENT On Air | The Road Ahead: Achieving Remission for Patients With Asthma

Join Professors Klaus Rabe and Ian Pavord as they discuss the importance of on-treatment clinical remission as a goal in asthma management.

MD, PhD, FERS

Klaus Rabe +1 more

24 minutes

Learning objectives

Explain the significance of on-treatment clinical remission in asthma management
Identify the main components of on-treatment clinical remission
Discuss how type 2 inflammatory biomarkers can provide an individualized understanding of patients' disease

Description

Join renowned pulmonologists Klaus Rabe, MD, PhD, FERS, and Ian Pavord, DM, FRCP, FERS, as they discuss on-treatment clinical remission as a goal in asthma management beyond disease control and highlight the role of type 2 inflammatory biomarkers in optimizing patient outcomes.

About these experts

Pulmonology

MD, PhD, FERS

Klaus Rabe

Professor of Pulmonary Medicine | University of Kiel; Director of the Department of Pneumology | LungClinic Grosshansdorf, Kiel, Germany

Pulmonology

DM, FERS, FMedSci, FRCP

Ian D. Pavord

Professor of Respiratory Medicine | University of Oxford; Honorary Consultant Physician | Oxford University Hospitals, United Kingdom

Related resources

Pulmonology

17 min

videoanimation

Exacerbations Lead to Worsening Lung Function

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: IndiaChange country/region

ADVENT On Air | The Road Ahead: Achieving Remission for ​Patients With Asthma

Learning objectives

Description

About these experts

Klaus Rabe

Ian D. Pavord

Related resources

GINA Asthma Decision Tree

Asthma White Board Video

EAACI 2024 Moving Beyond Control To On-Treatment Clinical Remission